# Chen_lab_analysis

## Overall AMP-AD analysis (limma pipeline)
+ [Disease status](https://github.com/ningxinkang/Chen_lab_analysis/blob/main/AMP-AD/AMP-AD_limma_diagnosis.md)
+ [APOE4 carrier](https://github.com/ningxinkang/Chen_lab_analysis/blob/main/AMP-AD/AMP-AD_limma_APOE_carrier.md)
+ [APOE4 dose](https://github.com/ningxinkang/Chen_lab_analysis/blob/main/AMP-AD/AMP-AD_limma_APOE_dose.md)

## Candidate genes
+ [LDs related genes (limma pipeline summary)](https://github.com/ningxinkang/Chen_lab_analysis/tree/main/AMP-AD_candidate_limma)
  + [diagnosis](https://github.com/ningxinkang/Chen_lab_analysis/tree/main/AMP-AD_candidate_limma/diagnosis)
  + [diagnosis and sex](https://github.com/ningxinkang/Chen_lab_analysis/tree/main/AMP-AD_candidate_limma/diagnosis%26sex)
  + [APOE dose](https://github.com/ningxinkang/Chen_lab_analysis/tree/main/AMP-AD_candidate_limma/APOE_dose)
  + [APOE dose and sex](https://github.com/ningxinkang/Chen_lab_analysis/tree/main/AMP-AD_candidate_limma/APOE_dose%26sex)
  + [APOE carrier](https://github.com/ningxinkang/Chen_lab_analysis/tree/main/AMP-AD_candidate_limma/APOE_carrier)
  + [APOE carrier and sex](https://github.com/ningxinkang/Chen_lab_analysis/tree/main/AMP-AD_candidate_limma/APOE_carrier%26sex)
+ [LDs related genes (ANOVA)](https://github.com/ningxinkang/Chen_lab_analysis/tree/main/AMP-AD_candidate_ANOVA)
+ [LDs related genes (t-test)](https://github.com/ningxinkang/Chen_lab_analysis/tree/main/AMP-AD_candidate_t)
+ [LDs related genes (braak stage)](https://github.com/ningxinkang/Chen_lab_analysis/tree/main/AMP-AD_candidate_braak)
+ [Chromogranin A (CgA)](https://github.com/ningxinkang/Chen_lab_analysis/blob/main/AMP-AD/AMP-AD_CGA.md)(CHGA in human genome)

## Update log
11/15/2022:
+ Update comprehensive DE analysis results using limma and DESeq2 pipeline
+ Update simple DE analysis using t-test and ANOVA on candidate genes
+ Update result summary of comprehensive DE analysis on candidate genes
+ Update CGA analysis

11/22/2022:
+ Update metadata, speecifically the **tissue** information of MSBB study
+ Update limma result (with new analysis regarding APOE carrier/dose) after metadata updates
